|
|
|
|
| LEADER |
06194nma a2201693 u 4500 |
| 001 |
EB002159074 |
| 003 |
EBX01000000000000001297189 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
230515 ||| eng |
| 020 |
|
|
|a books978-3-0365-7254-3
|
| 020 |
|
|
|a 9783036572550
|
| 020 |
|
|
|a 9783036572543
|
| 100 |
1 |
|
|a Ashiru-Oredope, Diane
|
| 245 |
0 |
0 |
|a Antimicrobial Prescribing and Stewardship, 1st Volume
|h Elektronische Ressource
|
| 260 |
|
|
|a Basel
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2023
|
| 300 |
|
|
|a 1 electronic resource (372 p.)
|
| 653 |
|
|
|a Africa
|
| 653 |
|
|
|a antibiotics use
|
| 653 |
|
|
|a stewardship
|
| 653 |
|
|
|a antibiotic use
|
| 653 |
|
|
|a health policy
|
| 653 |
|
|
|a barriers and enablers
|
| 653 |
|
|
|a pharyngitis
|
| 653 |
|
|
|a quality of health care
|
| 653 |
|
|
|a bone infection
|
| 653 |
|
|
|a microbial resistance
|
| 653 |
|
|
|a septic arthritis
|
| 653 |
|
|
|a joint infection
|
| 653 |
|
|
|a behavior change
|
| 653 |
|
|
|a veterinary
|
| 653 |
|
|
|a clinical pathways
|
| 653 |
|
|
|a multiplex PCR
|
| 653 |
|
|
|a prospective audit and feedback
|
| 653 |
|
|
|a outcomes
|
| 653 |
|
|
|a antimicrobial resistance
|
| 653 |
|
|
|a knowledge
|
| 653 |
|
|
|a mortality
|
| 653 |
|
|
|a therapy
|
| 653 |
|
|
|a SARS-CoV-2
|
| 653 |
|
|
|a infection prevention and control
|
| 653 |
|
|
|a Gram negative bacteremia
|
| 653 |
|
|
|a bloodstream infection
|
| 653 |
|
|
|a AMS
|
| 653 |
|
|
|a antimicrobial resistance (AMR)
|
| 653 |
|
|
|a pharmacist
|
| 653 |
|
|
|a multidisciplinary
|
| 653 |
|
|
|a older adults
|
| 653 |
|
|
|a bacteremia
|
| 653 |
|
|
|a delayed/back-up prescribing
|
| 653 |
|
|
|a resistance patterns
|
| 653 |
|
|
|a ethical trials
|
| 653 |
|
|
|a antibiotic
|
| 653 |
|
|
|a anti-infective agents
|
| 653 |
|
|
|a fluoroquinolones
|
| 653 |
|
|
|a antimicrobial stewardship
|
| 653 |
|
|
|a low- and middle-income countries
|
| 653 |
|
|
|a antibiotic stewardship
|
| 653 |
|
|
|a low-and middle-income countries
|
| 653 |
|
|
|a antibiotic resistance
|
| 653 |
|
|
|a community health workers
|
| 653 |
|
|
|a family practice
|
| 653 |
|
|
|a burn care
|
| 653 |
|
|
|a attitudes
|
| 653 |
|
|
|a antimicrobial stewardship intervention
|
| 653 |
|
|
|a acute otitis media
|
| 653 |
|
|
|a metronidazole
|
| 653 |
|
|
|a antibiotic stewardship program
|
| 653 |
|
|
|a wound care
|
| 653 |
|
|
|a sepsis
|
| 653 |
|
|
|a epidemiology
|
| 653 |
|
|
|a Medicine and Nursing / bicssc
|
| 653 |
|
|
|a antibiotic therapy
|
| 653 |
|
|
|a fosfomycin
|
| 653 |
|
|
|a emergency departments
|
| 653 |
|
|
|a risk factors
|
| 653 |
|
|
|a complex intervention
|
| 653 |
|
|
|a prescribing
|
| 653 |
|
|
|a pediatric infectious disease
|
| 653 |
|
|
|a resistance
|
| 653 |
|
|
|a critically ill patients
|
| 653 |
|
|
|a FilmArray
|
| 653 |
|
|
|a candidemia
|
| 653 |
|
|
|a nurse
|
| 653 |
|
|
|a antimicrobial
|
| 653 |
|
|
|a antimicrobial stewardship (AMS)
|
| 653 |
|
|
|a smartphone apps
|
| 653 |
|
|
|a pharmacy
|
| 653 |
|
|
|a coronavirus
|
| 653 |
|
|
|a hematologic diseases
|
| 653 |
|
|
|a Theoretical Domains Framework
|
| 653 |
|
|
|a urinary infection
|
| 653 |
|
|
|a Nepal
|
| 653 |
|
|
|a osteomyelitis
|
| 653 |
|
|
|a prescription
|
| 653 |
|
|
|a PDSA cycle
|
| 653 |
|
|
|a culture and sensitivity testing
|
| 653 |
|
|
|a Helicobacter pylori
|
| 653 |
|
|
|a medical students
|
| 653 |
|
|
|a Ghana
|
| 653 |
|
|
|a children
|
| 653 |
|
|
|a antimicrobial prescribing
|
| 653 |
|
|
|a health practitioners
|
| 653 |
|
|
|a COVID-19
|
| 653 |
|
|
|a encephalitis
|
| 653 |
|
|
|a meningitis
|
| 653 |
|
|
|a adolescents
|
| 653 |
|
|
|a upper respiratory tract infections
|
| 653 |
|
|
|a Uganda
|
| 653 |
|
|
|a public health
|
| 653 |
|
|
|a wound management
|
| 653 |
|
|
|a training
|
| 653 |
|
|
|a complementarity
|
| 653 |
|
|
|a general practice
|
| 653 |
|
|
|a prescribing appropriateness
|
| 653 |
|
|
|a obesity
|
| 653 |
|
|
|a follow-up blood cultures
|
| 653 |
|
|
|a animal health
|
| 653 |
|
|
|a proton pump inhibitors
|
| 653 |
|
|
|a leaflet
|
| 653 |
|
|
|a one health
|
| 653 |
|
|
|a clarithromycin
|
| 653 |
|
|
|a amoxicillin
|
| 653 |
|
|
|a rapid diagnostic technology
|
| 653 |
|
|
|a urinary tract infections (UTI)
|
| 653 |
|
|
|a enterococcal
|
| 653 |
|
|
|a UK
|
| 653 |
|
|
|a antimicrobials
|
| 653 |
|
|
|a LMICs
|
| 653 |
|
|
|a antibiotics
|
| 653 |
|
|
|a qualitative
|
| 653 |
|
|
|a developing countries
|
| 653 |
|
|
|a CwPAMS App
|
| 700 |
1 |
|
|a Ashiru-Oredope, Diane
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
| 500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/
|
| 028 |
5 |
0 |
|a 10.3390/books978-3-0365-7254-3
|
| 856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/7185
|7 0
|x Verlag
|3 Volltext
|
| 856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/100092
|z DOAB: description of the publication
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
|
|a 700
|
| 082 |
0 |
|
|a 600
|
| 520 |
|
|
|a This Antimicrobial Prescribing and Stewardship Issue (volume 1) consist of manuscripts, including original research, review articles, case series, and opinion papers for topics related to antimicrobial (antibiotic, antifungal) stewardship, including: Disease-based/organism-based antimicrobial stewardship;Diagnostic stewardship;Influence of antimicrobial utilisation changes in antimicrobial resistance;Impact of antimicrobial stewardship on quality performance measures and patient outcomes;Novel antimicrobial stewardship education and training approaches or interventions aimed at the public and/or healthcare workers;Behavioural change approaches to antimicrobial stewardship;Collaborative practice agreements in antimicrobial stewardship;Antimicrobial stewardship in special populations (e.g., paediatrics, geriatrics, emergency medicine, hematology/oncology);Tackling AMR through antimicrobial stewardship in low- and middle-income countries;Antimicrobial stewardship for animal health;Antimicrobial stewardship in alternative settings (e.g., community practice, long-term care, and resource-limited small and rural hospitals);Antimicrobial use and stewardship in the context of the COVID-19 pandemic;Global collaborations to tackle AMR through antimicrobial stewardship.
|